Seagen
SGEN
#580
Rank
NZ$76.89 B
Marketcap
NZ$407.59
Share price
-0.07%
Change (1 day)
72.27%
Change (1 year)

Seagen (SGEN) - Net assets

Net assets on the balance sheet as of September 2023 : NZ$4.54 Billion

According to Seagen 's latest financial reports the company has NZ$4.54 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Seagen - Net assets on balance sheet (from 2001 to 2023)

Net assets by year

Year Net assets Change
2022-12-31$NZ$4.41 B-1.59%
2021-12-31$NZ$4.48 B-7.17%
2020-12-31$NZ$4.83 B73.52%
2019-12-31$NZ$2.78 B46.69%
2018-12-31$NZ$1.89 B99.07%
2017-12-31$NZ$0.95 B4.22%
2016-12-31$NZ$0.91 B-8.66%
2015-12-31$NZ$1.00 B272.44%
2014-12-31$NZ$0.26 B-3.94%
2013-12-31$NZ$0.28 B1.89%
2012-12-31$NZ$0.27 B-1.96%
2011-12-31$NZ$0.28 B33.94%
2010-12-31$NZ$0.20 B-26.25%
2009-12-31$NZ$0.28 B108.5%
2008-12-31$NZ$0.13 B93.2%
2007-12-31$NZ$70.47 M-43.73%
2006-12-31$NZ$0.12 B13.45%
2005-12-31$NZ$0.11 B-24.13%
2004-12-31$NZ$0.14 B26.33%
2003-12-31$NZ$0.11 B29.08%
2002-12-31$NZ$89.23 M-38.92%
2001-12-31$NZ$0.14 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
NZ$152.33 B 3,252.08%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-NZ$10.5 Billion-330.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$33.58 B 639.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$39.77 B 775.11%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$40.55 B 792.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
NZ$47.76 M-98.95%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
NZ$1.00 B-77.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$1.27 B-71.98%๐Ÿ‡บ๐Ÿ‡ธ USA